Arteriosclerosis, Vol 9, 159-166, Copyright © 1989 by American Heart Association

ARTICLES

Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit

Y Arad, JJ Badimon, L Badimon, WC Hembree and HN Ginsberg
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032.

The concentration of dehydroepiandrosterone sulfate (DHEA-S) in human plasma is higher than any other steroid. Recent evidence has suggested an inverse relationship between plasma DHEA levels and the development of coronary atherosclerosis in humans. We used the cholesterol-fed rabbit model to investigate whether DHEA feeding would diminish aortic fatty streak formation in this model. Fifteen New Zealand White rabbits were fed rabbit chow supplemented with 0.5% cholesterol (wt/wt). Seven animals were, in addition, fed DHEA, 0.5% of diet (wt/wt). Animals were sacrificed after 2 months, and the aortic involvement with fatty streaks was evaluated by computerized planimetry of Sudan IV-stained aortas and by chemical analysis of aortic wall lipids. Compared to controls, DHEA-fed animals had similar plasma levels of total, very low density lipoprotein (VLDL), low density lipoprotein (LDL), and high density lipoprotein (HDL) cholesterol, corticoids, and estrogens. DHEA- fed animals had higher plasma levels of total, VLDL, and LDL triglycerides and lower HDL triglycerides than did controls. DHEA feeding resulted in 30% and 40%, respectively, inhibition of fatty streak formation by chemical analysis and planimetry. We conclude that DHEA feeding inhibits the development of aortic fatty streaks in cholesterol-fed rabbits, independent of changes in plasma total and LDL cholesterol levels of DHEA conversion to estrogens or corticoids.

This article has been cited by other articles:

				D. Liu, M. Iruthayanathan, L. L. Homan, Y. Wang, L. Yang, Y. Wang, and J. S. Dillon Dehydroepiandrosterone Stimulates Endothelial Proliferation and Angiogenesis through Extracellular Signal-Regulated Kinase 1/2-Mediated Mechanisms Endocrinology, March 1, 2008; 149(3): 889 - 898. [Abstract] [Full Text] [PDF]

				P. Cocco, D. Fadda, and A.G. Schwartz Subjects expressing the glucose-6-phosphate dehydrogenase deficient phenotype experience a lower cardiovascular mortality QJM, February 1, 2008; 101(2): 161 - 163. [Full Text] [PDF]

				A Dagre, J Lekakis, C Mihas, A Protogerou, L Thalassinou, D Tryfonopoulos, G Douridas, C Papamichael, and M Alevizaki Association of dehydroepiandrosterone-sulfate with endothelial function in young women with polycystic ovary syndrome. Eur. J. Endocrinol., June 1, 2006; 154(6): 883 - 890. [Abstract] [Full Text] [PDF]

				R. P. Brandes, I. Fleming, and R. Busse Endothelial aging Cardiovasc Res, May 1, 2005; 66(2): 286 - 294. [Abstract] [Full Text] [PDF]

				M. K. C. Ng, S. Nakhla, A. Baoutina, W. Jessup, D. J. Handelsman, and D. S. Celermajer Dehydroepiandrosterone, an adrenalandrogen, increases human foam cell formation: a potentially pro-atherogenic effect J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1967 - 1974. [Abstract] [Full Text] [PDF]

				K. K. Dhatariya and K. S. Nair Dehydroepiandrosterone: Is There a Role for Replacement? Mayo Clin. Proc., October 1, 2003; 78(10): 1257 - 1273. [Abstract] [PDF]

				H. Kawano, H. Yasue, A. Kitagawa, N. Hirai, T. Yoshida, H. Soejima, S. Miyamoto, M. Nakano, and H. Ogawa Dehydroepiandrosterone Supplementation Improves Endothelial Function and Insulin Sensitivity in Men J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3190 - 3195. [Abstract] [Full Text] [PDF]

				P. Y. Liu, A. K. Death, and D. J. Handelsman Androgens and Cardiovascular Disease Endocr. Rev., June 1, 2003; 24(3): 313 - 340. [Abstract] [Full Text] [PDF]

				F. C. W. Wu and A. von Eckardstein Androgens and Coronary Artery Disease Endocr. Rev., April 1, 2003; 24(2): 183 - 217. [Abstract] [Full Text] [PDF]

				D. Liu and J. S. Dillon Dehydroepiandrosterone Activates Endothelial Cell Nitric-oxide Synthase by a Specific Plasma Membrane Receptor Coupled to Galpha i2,3 J. Biol. Chem., June 7, 2002; 277(24): 21379 - 21388. [Abstract] [Full Text] [PDF]

				H. A. Feldman, C. B. Johannes, A. B. Araujo, B. A. Mohr, C. Longcope, and J. B. McKinlay Low Dehydroepiandrosterone and Ischemic Heart Disease in Middle-aged Men: Prospective Results from the Massachusetts Male Aging Study Am. J. Epidemiol., January 1, 2001; 153(1): 79 - 89. [Abstract] [Full Text] [PDF]

				C. P. Sparrow, C. A. Burton, M. Hernandez, S. Mundt, H. Hassing, S. Patel, R. Rosa, A. Hermanowski-Vosatka, P.-R. Wang, D. Zhang, et al. Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering Arterioscler Thromb Vasc Biol, January 1, 2001; 21(1): 115 - 121. [Abstract] [Full Text] [PDF]

				S. Kiechl, J. Willeit, E. Bonora, S. Schwarz, and Q. Xu No Association Between Dehydroepiandrosterone Sulfate and Development of Atherosclerosis in a Prospective Population Study (Bruneck Study) Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1094 - 1100. [Abstract] [Full Text] [PDF]

				T. Hayashi, T. Esaki, E. Muto, H. Kano, Y. Asai, N. K. Thakur, D. Sumi, M. Jayachandran, and A. Iguchi Dehydroepiandrosterone Retards Atherosclerosis Formation Through Its Conversion to Estrogen : The Possible Role of Nitric Oxide Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 782 - 792. [Abstract] [Full Text] [PDF]

				G.P. Bernini, M. Sgro’, A. Moretti, G.F. Argenio, C.O. Barlascini, R. Cristofani, and A. Salvetti Endogenous Androgens and Carotid Intimal-Medial Thickness in Women J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2008 - 2012. [Abstract] [Full Text]

				P. Alexandersen, J. Haarbo, I. Byrjalsen, H. Lawaetz, and C. Christiansen Natural Androgens Inhibit Male Atherosclerosis : A Study in Castrated, Cholesterol-Fed Rabbits Circ. Res., April 16, 1999; 84(7): 813 - 819. [Abstract] [Full Text] [PDF]

				T. D. Pugh, T. D. Oberley, and R. Weindruch Dietary Intervention at Middle Age: Caloric Restriction but not Dehydroepiandrosterone Sulfate Increases Lifespan and Lifetime Cancer Incidence in Mice Cancer Res., April 1, 1999; 59(7): 1642 - 1648. [Abstract] [Full Text] [PDF]

				N. H. Bjarnason, J. Haarbo, I. Byrjalsen, R. F. Kauffman, and C. Christiansen Raloxifene Inhibits Aortic Accumulation of Cholesterol in Ovariectomized, Cholesterol-Fed Rabbits Circulation, September 16, 1997; 96(6): 1964 - 1969. [Abstract] [Full Text]

				J. E. Metherall, H. Li, and K. Waugh Role of Multidrug Resistance P-glycoproteins in Cholesterol Biosynthesis J. Biol. Chem., February 2, 1996; 271(5): 2634 - 2640. [Abstract] [Full Text] [PDF]

				M. Barbagallo, J. Shan, P. K.T. Pang, and L. M. Resnick Effects of Dehydroepiandrosterone Sulfate on Cellular Calcium Responsiveness and Vascular Contractility Hypertension, December 1, 1995; 26(6): 1065 - 1069. [Abstract] [Full Text]